A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
Menu
Month: July 2021
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
Noted trauma surgeon Hasan Alam, MD, takes the reins of the Department of Surgery and as the Loyal and Edith Davis Professor of Surgery, and professor of Cell and Developmental Biology.
Four Northwestern Medicine hospitals have been recognized by U.S. News & World Report in its 2020-21 Best Hospitals rankings, with Northwestern Memorial Hospital named among the top 10 hospitals in the U.S.
Blessing Aghaulor, MD, MPH, a former resident in internal medicine and current fellow in Gastroenterology and Hepatology, has conducted research on transplant outcomes and consulted about patients at the ERASE trafficking clinic in Chicago.
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
Measuring levels of hypervigilance and anxiety may improve healthcare providers’ understanding of severe esophageal diseases and treatment strategies, according to a Northwestern Medicine study.
Medical student David Younessi recently authored a paper that highlighted price disparities between Medicare and VA reimbursements for several ophthalmic procedures.
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
Thirty-five years since it was started, the Coronary Artery Risk Development in Young Adults study, or CARDIA, has become a premier source for the determinants, mechanism and outcomes of cardiovascular disease and manifestations of aging.